These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10695104)

  • 1. Risk factor modification extends the benefit of coronary artery revascularisation procedures.
    Shepherd J
    Int J Clin Pract; 1999; 53(5):376-80. PubMed ID: 10695104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does diabetes change the anti-ischemic therapeutic options in the symptomatic coronary patient?].
    Bory M
    Arch Mal Coeur Vaiss; 2000 Dec; 93 Spec No 4():45-50. PubMed ID: 11296462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Coronary angioplasty compared with aortocoronary bypass in patients with multivascular coronary disease].
    Morocutti G; Vendrametto F; Werren M; Spedicato L; Bernardi G; Gregori D; Fioretti PM
    Ital Heart J Suppl; 2000 Jun; 1(6):759-65. PubMed ID: 11204007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of repeat coronary artery surgery.
    Noyez L
    EuroIntervention; 2009 May; 5 Suppl D():D30-3. PubMed ID: 19736067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncardiac surgery following percutaneous coronary intervention.
    Mendoza CE; Virani SS; Shah N; Ferreira AC; de Marchena E
    Catheter Cardiovasc Interv; 2004 Nov; 63(3):267-73. PubMed ID: 15505859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narrowing the gap: early and intermediate outcomes after percutaneous coronary intervention and coronary artery bypass graft procedures in California, 1997 to 2006.
    Carey JS; Danielsen B; Milliken J; Li Z; Stabile BE
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1100-7. PubMed ID: 19837215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on percutaneous coronary intervention vs. coronary artery bypass graft surgery.
    Karki DB; Neopane A
    Kathmandu Univ Med J (KUMJ); 2003; 1(4):284-7. PubMed ID: 16388272
    [No Abstract]   [Full Text] [Related]  

  • 14. Angioplasty in severe heart attack. Anesthesia and general management.
    Ranucci M
    Minerva Anestesiol; 2002 Apr; 68(4):192-5. PubMed ID: 12024081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coronary angioplasty in elderly patients].
    Liistro F; Colombo A
    Ital Heart J Suppl; 2002 Jan; 3(1):1-8. PubMed ID: 11899566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of conduits for coronary artery bypass grafting: craft or science?
    Buxton BF; Hayward PA; Newcomb AE; Moten S; Seevanayagam S; Gordon I
    Eur J Cardiothorac Surg; 2009 Apr; 35(4):658-70. PubMed ID: 19231230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of clopidogrel in coronary artery disease.
    Sureddi RK
    J Ark Med Soc; 2007 Feb; 103(8):201-3. PubMed ID: 17436832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
    EUROASPIRE II Study Group
    Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II).
    Soares PR; Hueb WA; Lemos PA; Lopes N; Martinez EE; Cesar LA; Oliveira SA; Ramires JA
    Circulation; 2006 Jul; 114(1 Suppl):I420-4. PubMed ID: 16820611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.